Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Quantitative expression of MMPs 2, 9, 14, and collagen IV in LCIS and paired normal breast tissue.

Nyante SJ, Wang T, Tan X, Ozdowski EF, Lawton TJ.

Sci Rep. 2019 Sep 17;9(1):13432. doi: 10.1038/s41598-019-48602-6.

2.

Radiology Resident Journal Club: Enhancements Add Educational Value.

Rodriguez J, Nyante SJ, Henderson L, Smith JK, Beck Dallaghan GL, Jordan SG.

Acad Radiol. 2019 Jul 5. pii: S1076-6332(19)30309-5. doi: 10.1016/j.acra.2019.06.007. [Epub ahead of print]

PMID:
31281084
3.

Supplemental Breast Imaging Utilization After Breast Density Legislation in North Carolina.

Nyante SJ, Marsh MW, Benefield T, Earnhardt K, Lee SS, Henderson LM.

J Am Coll Radiol. 2019 Jul 1. pii: S1546-1440(19)30706-9. doi: 10.1016/j.jacr.2019.05.054. [Epub ahead of print]

PMID:
31271735
4.

Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study.

Nyante SJ, Biritwum R, Figueroa J, Graubard B, Awuah B, Addai BW, Yarney J, Clegg-Lamptey JN, Ansong D, Nyarko K, Wiafe S, Oppong J, Boakye I, Brotzman M, Adjei R, Afriyie LT, Garcia-Closas M, Brinton LA.

PLoS One. 2019 Apr 16;14(4):e0215347. doi: 10.1371/journal.pone.0215347. eCollection 2019.

5.

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype.

Couture HD, Williams LA, Geradts J, Nyante SJ, Butler EN, Marron JS, Perou CM, Troester MA, Niethammer M.

NPJ Breast Cancer. 2018 Sep 3;4:30. doi: 10.1038/s41523-018-0079-1. eCollection 2018.

6.

PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.

Puvanesarajah S, Nyante SJ, Kuzmiak CM, Chen M, Tse CK, Sun X, Allott EH, Kirk EL, Carey LA, Perou CM, Olshan AF, Henderson LM, Troester MA.

Cancer Prev Res (Phila). 2018 Jun;11(6):327-336. doi: 10.1158/1940-6207.CAPR-17-0368. Epub 2018 Apr 5.

7.

Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.

Mullooly M, Khodr ZG, Dallal CM, Nyante SJ, Sherman ME, Falk R, Liao LM, Love J, Brinton LA, Gierach GL.

Am J Epidemiol. 2017 Dec 15;186(12):1329-1340. doi: 10.1093/aje/kwx206.

8.

Design considerations for identifying breast cancer risk factors in a population-based study in Africa.

Brinton LA, Awuah B, Nat Clegg-Lamptey J, Wiafe-Addai B, Ansong D, Nyarko KM, Wiafe S, Yarney J, Biritwum R, Brotzman M, Adjei AA, Adjei E, Aitpillah F, Edusei L, Dedey F, Nyante SJ, Oppong J, Osei-Bonsu E, Titiloye N, Vanderpuye V, Brew Abaidoo E, Arhin B, Boakye I, Frempong M, Ohene Oti N, Okyne V, Figueroa JD.

Int J Cancer. 2017 Jun 15;140(12):2667-2677. doi: 10.1002/ijc.30688. Epub 2017 Mar 28.

9.

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.

Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL.

Breast Cancer Res. 2017 Jan 19;19(1):8. doi: 10.1186/s13058-016-0791-4.

10.

Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies.

Gaudet MM, Carter BD, Brinton LA, Falk RT, Gram IT, Luo J, Milne RL, Nyante SJ, Weiderpass E, Beane Freeman LE, Sandler DP, Robien K, Anderson KE, Giles GG, Chen WY, Feskanich D, Braaten T, Isaacs C, Butler LM, Koh WP, Wolk A, Adami HO, White E, Margolis KL, Thun MJ, Gapstur SM.

Int J Epidemiol. 2017 Jun 1;46(3):881-893. doi: 10.1093/ije/dyw288.

11.

Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.

Gierach GL, Curtis RE, Pfeiffer RM, Mullooly M, Ntowe EA, Hoover RN, Nyante SJ, Feigelson HS, Glass AG, Berrington de Gonzalez A.

JAMA Oncol. 2017 Feb 9;3(2):186-193. doi: 10.1001/jamaoncol.2016.3340. Epub 2016 Oct 6.

12.

The association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohort.

Nyante SJ, Lee SS, Benefield TS, Hoots TN, Henderson LM.

Cancer. 2017 Jan 1;123(2):219-227. doi: 10.1002/cncr.30281. Epub 2016 Sep 28.

13.

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Singhal S, Pawlish K, Peters ES, Bock CH, Stram A, Van Den Berg DJ, Edlund CK, Conti DV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A, Kong Y, Pregja SL, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber MR, Goodman PJ, Hennis AJ, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy AB, Nemesure B, Neslund-Dudas C, Strom SS, Vij R, Rybicki BA, Stanford JL, Signorello LB, Witte JS, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Birmann BM, Ingles SA, Press MF, Atanackovic D, Glenn MJ, Cannon-Albright LA, Jones B, Tricot G, Martin TG, Kumar SK, Wolf JL, Deming Halverson SL, Rothman N, Brooks-Wilson AR, Rajkumar SV, Kolonel LN, Chanock SJ, Slager SL, Severson RK, Janakiraman N, Terebelo HR, Brown EE, De Roos AJ, Mohrbacher AF, Colditz GA, Giles GG, Spinelli JJ, Chiu BC, Munshi NC, Anderson KC, Levy J, Zonder JA, Orlowski RZ, Lonial S, Camp NJ, Vachon CM, Ziv E, Stram DO, Hazelett DJ, Haiman CA, Cozen W.

Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1609-1618. Epub 2016 Sep 1.

14.

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Berrington de Gonzalez A, Sherman ME, Gierach GL.

J Clin Oncol. 2016 Jun 20;34(18):2093-7. doi: 10.1200/JCO.2015.64.4492. Epub 2016 Mar 28. No abstract available.

15.

Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen.

Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Bowles EJ, Hoover RN, Glass A, Gierach GL.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):212-6. doi: 10.1158/1055-9965.EPI-15-0412. Epub 2015 Nov 6.

16.

Performance of digital screening mammography in a population-based cohort of black and white women.

Henderson LM, Benefield T, Nyante SJ, Marsh MW, Greenwood-Hickman MA, Schroeder BF.

Cancer Causes Control. 2015 Oct;26(10):1495-9. doi: 10.1007/s10552-015-0631-3. Epub 2015 Jul 17.

17.

Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA.

Prostate. 2015 Aug 1;75(11):1167-76. doi: 10.1002/pros.22998. Epub 2015 Apr 28.

18.

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.

Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Gierach GL.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju425. doi: 10.1093/jnci/dju425. Print 2015 Mar.

19.

Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC.

Cancer Causes Control. 2015 Jan;26(1):121-31. doi: 10.1007/s10552-014-0491-2. Epub 2014 Nov 25.

20.

Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.

Brinton LA, Smith L, Gierach GL, Pfeiffer RM, Nyante SJ, Sherman ME, Park Y, Hollenbeck AR, Dallal CM.

Cancer Causes Control. 2014 Jul;25(7):843-57. doi: 10.1007/s10552-014-0385-3. Epub 2014 May 9.

21.

Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort.

Nyante SJ, Gierach GL, Dallal CM, Freedman ND, Park Y, Danforth KN, Hollenbeck AR, Brinton LA.

Br J Cancer. 2014 Apr 29;110(9):2339-47. doi: 10.1038/bjc.2014.132. Epub 2014 Mar 18.

22.

Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Tsilidis KK, Rohrmann S, McGlynn KA, Nyante SJ, Lopez DS, Bradwin G, Feinleib M, Joshu CE, Kanarek N, Nelson WG, Selvin E, Platz EA.

Andrology. 2013 Nov;1(6):919-28. doi: 10.1111/j.2047-2927.2013.00129.x. Epub 2013 Sep 30.

23.

Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.

Nyante SJ, Dallal CM, Gierach GL, Park Y, Hollenbeck AR, Brinton LA.

Am J Epidemiol. 2013 Aug 1;178(3):359-71. doi: 10.1093/aje/kws471. Epub 2013 Jun 13.

24.

Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study.

Bensen JT, Tse CK, Nyante SJ, Barnholtz-Sloan JS, Cole SR, Millikan RC.

Cancer Causes Control. 2013 Jun;24(6):1099-109. doi: 10.1007/s10552-013-0187-z. Epub 2013 Mar 23.

25.

Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men.

Trabert B, Graubard BI, Nyante SJ, Rifai N, Bradwin G, Platz EA, McQuillan GM, McGlynn KA.

Cancer Causes Control. 2012 Dec;23(12):1881-91. doi: 10.1007/s10552-012-0024-9. Epub 2012 Sep 28.

26.

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomäki K, Amiano P, Apicella C; Australian Breast Cancer Tissue Bank Investigators, Baglietto L, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Brauch H, Brinton L, Bui QM, Buring JE, Buys SS, Campa D, Carpenter JE, Chasman DI, Chang-Claude J, Chen C, Clavel-Chapelon F, Cox A, Cross SS, Czene K, Deming SL, Diasio RB, Diver WR, Dunning AM, Durcan L, Ekici AB, Fasching PA; Familial Breast Cancer Study, Feigelson HS, Fejerman L, Figueroa JD, Fletcher O, Flesch-Janys D, Gaudet MM; GENICA Consortium, Gerty SM, Rodriguez-Gil JL, Giles GG, van Gils CH, Godwin AK, Graham N, Greco D, Hall P, Hankinson SE, Hartmann A, Hein R, Heinz J, Hoover RN, Hopper JL, Hu JJ, Huntsman S, Ingles SA, Irwanto A, Isaacs C, Jacobs KB, John EM, Justenhoven C, Kaaks R, Kolonel LN, Coetzee GA, Lathrop M, Le Marchand L, Lee AM, Lee IM, Lesnick T, Lichtner P, Liu J, Lund E, Makalic E, Martin NG, McLean CA, Meijers-Heijboer H, Meindl A, Miron P, Monroe KR, Montgomery GW, Müller-Myhsok B, Nickels S, Nyante SJ, Olswold C, Overvad K, Palli D, Park DJ, Palmer JR, Pathak H, Peto J, Pharoah P, Rahman N, Rivadeneira F, Schmidt DF, Schmutzler RK, Slager S, Southey MC, Stevens KN, Sinn HP, Press MF, Ross E, Riboli E, Ridker PM, Schumacher FR, Severi G, Dos Santos Silva I, Stone J, Sund M, Tapper WJ, Thun MJ, Travis RC, Turnbull C, Uitterlinden AG, Waisfisz Q, Wang X, Wang Z, Weaver J, Schulz-Wendtland R, Wilkens LR, Van Den Berg D, Zheng W, Ziegler RG, Ziv E, Nevanlinna H, Easton DF, Hunter DJ, Henderson BE, Chanock SJ, Garcia-Closas M, Kraft P, Haiman CA, Vachon CM.

Hum Mol Genet. 2012 Dec 15;21(24):5373-84. doi: 10.1093/hmg/dds381. Epub 2012 Sep 13.

27.

Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004.

Nyante SJ, Graubard BI, Li Y, McQuillan GM, Platz EA, Rohrmann S, Bradwin G, McGlynn KA.

Int J Androl. 2012 Jun;35(3):456-66. doi: 10.1111/j.1365-2605.2011.01230.x. Epub 2011 Dec 13.

28.

Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium.

Pasaniuc B, Zaitlen N, Lettre G, Chen GK, Tandon A, Kao WH, Ruczinski I, Fornage M, Siscovick DS, Zhu X, Larkin E, Lange LA, Cupples LA, Yang Q, Akylbekova EL, Musani SK, Divers J, Mychaleckyj J, Li M, Papanicolaou GJ, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Ingles SA, Press MF, Chanock SJ, Deming SL, Rodriguez-Gil JL, Palmer CD, Buxbaum S, Ekunwe L, Hirschhorn JN, Henderson BE, Myers S, Haiman CA, Reich D, Patterson N, Wilson JG, Price AL.

PLoS Genet. 2011 Apr;7(4):e1001371. doi: 10.1371/journal.pgen.1001371. Epub 2011 Apr 21.

29.

Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.

Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC.

Breast Cancer Res Treat. 2011 Sep;129(2):593-606. doi: 10.1007/s10549-011-1517-z. Epub 2011 Apr 23.

30.

Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.

Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, Andaya AA, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Chanock S, Garcia-Closas M, Figueroa JD.

Breast Cancer Res. 2011 Apr 6;13(2):R42. doi: 10.1186/bcr2864.

31.

Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.

Nyante SJ, Black A, Kreimer AR, Duggan MA, Carreon JD, Kessel B, Buys SS, Ragard LR, Johnson KA, Dunn BK, Lamerato L, Commins JM, Berg CD, Sherman ME.

Gynecol Oncol. 2011 Mar;120(3):474-9. doi: 10.1016/j.ygyno.2010.11.015. Epub 2010 Dec 7.

32.

FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.

Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ, Millikan RC.

Carcinogenesis. 2010 Aug;31(8):1417-23. doi: 10.1093/carcin/bgq128. Epub 2010 Jun 16.

33.

Obesity and screening for breast, cervical, and colorectal cancer in women: a review.

Cohen SS, Palmieri RT, Nyante SJ, Koralek DO, Kim S, Bradshaw P, Olshan AF.

Cancer. 2008 May 1;112(9):1892-904. doi: 10.1002/cncr.23408. Review.

34.

The association between oral contraceptive use and lobular and ductal breast cancer in young women.

Nyante SJ, Gammon MD, Malone KE, Daling JR, Brinton LA.

Int J Cancer. 2008 Feb 15;122(4):936-41.

35.

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.

Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM.

Cancer. 2004 Jun 15;100(12):2562-72.

36.

Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer.

Nyante SJ, Devries S, Chen YY, Hwang ES.

Hum Pathol. 2004 Jun;35(6):759-63.

PMID:
15188144

Supplemental Content

Loading ...
Support Center